96 related articles for article (PubMed ID: 22222779)
1. Outpatient therapeutic nuclear oncology.
Turner JH
Ann Nucl Med; 2012 May; 26(4):289-97. PubMed ID: 22222779
[TBL] [Abstract][Full Text] [Related]
2. Outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
Willegaignon J; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Clin Nucl Med; 2011 Jun; 36(6):440-5. PubMed ID: 21552020
[TBL] [Abstract][Full Text] [Related]
3. Commentary on Willegaignon et al.: outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
Marcus CS
Clin Nucl Med; 2011 Jun; 36(6):446. PubMed ID: 21552021
[No Abstract] [Full Text] [Related]
4. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
5. [Nuclear medicine meets radiation therapy- the radiooncologist's view].
Schütze C; Krause M; Yaromina A; Zips D; Baumann M
Nuklearmedizin; 2010; 49 Suppl 1():S11-5. PubMed ID: 21152683
[TBL] [Abstract][Full Text] [Related]
6. Minimizing and communicating radiation risk in pediatric nuclear medicine.
Fahey FH; Treves ST; Adelstein SJ
J Nucl Med Technol; 2012 Mar; 40(1):13-24. PubMed ID: 22393223
[TBL] [Abstract][Full Text] [Related]
7. Minimizing and communicating radiation risk in pediatric nuclear medicine.
Fahey FH; Treves ST; Adelstein SJ
J Nucl Med; 2011 Aug; 52(8):1240-51. PubMed ID: 21764783
[TBL] [Abstract][Full Text] [Related]
8. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
Padhy AK; Dondi M
Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry in nuclear medicine therapy.
Chiesa C; Lassmann M
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):2-4. PubMed ID: 21386781
[No Abstract] [Full Text] [Related]
10. Safety in radiation oncology: the role of international initiatives by the International Atomic Energy Agency.
Abdel-Wahab M; Rosenblatt E; Holmberg O; Meghzifene A
J Am Coll Radiol; 2011 Nov; 8(11):789-94. PubMed ID: 22051464
[TBL] [Abstract][Full Text] [Related]
11. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
Teh BS; Paulino A; Butler EB
Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
[TBL] [Abstract][Full Text] [Related]
12. Neutron-activated theranostic radionuclides for nuclear medicine.
Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
[TBL] [Abstract][Full Text] [Related]
13. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
Parthasarathy KL; Crawford ES
J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment.
Maecke HR; Reubi JC
J Nucl Med; 2011 Jun; 52(6):841-4. PubMed ID: 21571797
[TBL] [Abstract][Full Text] [Related]
15. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
[TBL] [Abstract][Full Text] [Related]
16. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416
[TBL] [Abstract][Full Text] [Related]
17. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.
Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A
Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825
[TBL] [Abstract][Full Text] [Related]
18. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
19. The importance of dosimetry in nuclear medicine therapy practice.
Bisi G
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):1. PubMed ID: 21386780
[No Abstract] [Full Text] [Related]
20. The development of radiotherapy: physics, technology methods.
Acta Oncol; 1996; 35 Suppl 6():24-30. PubMed ID: 9154081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
